Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000041

CFO and Treasurer sold 2,560 shares at $34.69 ($88,806)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Krognes Steve E. CFO and Treasurer 2022-02-11 Sale −2,560 $34.69 $88,806 120,221 D: show line 1 in the form
Open-market sales · 2,560 sh · avg $34.69 · $88,806
Loading xslF345X03/wf-form4_164496940391476.xml…